Chemoinformaics analysis of 5-(HEPTADEC-12-ENYL)-RESORCINOL
| Molecular Weight | 346.555 | nRot | 15 |
| Heavy Atom Molecular Weight | 308.251 | nRig | 7 |
| Exact Molecular Weight | 346.287 | nRing | 1 |
| Solubility: LogS | -3.806 | nHRing | 0 |
| Solubility: LogP | 8.339 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 65.3521 |
| nHD | 2 | BPOL | 38.1219 |
| QED | 0.258 |
| Synth | 2.337 |
| Natural Product Likeliness | 0.999 |
| NR-PPAR-gamma | 0.945 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.975 |
| MDCK | 0.0000113 |
| BBB | 0.058 |
| PPB | 0.991103 |
| VDSS | 5.022 |
| FU | 0.00769224 |
| CYP1A2-inh | 0.731 |
| CYP1A2-sub | 0.179 |
| CYP2c19-inh | 0.776 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.257 |
| CYP2c9-sub | 0.989 |
| CYP2d6-inh | 0.944 |
| CYP2d6-sub | 0.402 |
| CYP3a4-inh | 0.641 |
| CYP3a4-sub | 0.043 |
| CL | 7.396 |
| T12 | 0.489 |
| hERG | 0.239 |
| Ames | 0.019 |
| ROA | 0.018 |
| SkinSen | 0.973 |
| Carcinogencity | 0.033 |
| EI | 0.943 |
| Respiratory | 0.612 |
| NR-Aromatase | 0.635 |
| Antiviral | Yes |
| Prediction | 0.626958 |